Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
Röhrig U.F., Majjigapu S.R., Grosdidier A., Bron S., Stroobant V., Pilotte L., Colau D., Vogel P., Van den Eynde B.J., Zoete V. et al., 2012. Journal of Medicinal Chemistry, 55 (11) pp. 5270-5290. Peer-reviewed.
ici le détail